FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200339073> ?p ?o ?g. }

• W4200339073 endingPage "126" @default.
• W4200339073 startingPage "108" @default.
• W4200339073 abstract "The blood-brain barrier (BBB) and tumor heterogeneity have resulted in abysmally poor clinical outcomes in glioblastoma (GBM) with the standard therapeutic regimen. Despite several anti-glioma drug delivery strategies, the lack of adequate chemotherapeutic bioavailability in gliomas has led to a suboptimal therapeutic gain in terms of improvement in survival and increased systemic toxicities. This has paved the way for designing highly specific and non-invasive drug delivery approaches for treating GBM. The intranasal (IN) route is one such delivery strategy that has the potential to reach the brain parenchyma by circumventing the BBB. We recently showed that in situ hydrogel embedded with miltefosine (HePc, proapoptotic anti-tumor agent) and temozolomide (TMZ, DNA methylating agent) loaded targeted nanovesicles prevented tumor relapses in orthotopic GBM mouse models. In this study, we specifically investigated the potential of a non-invasive IN route of TMZ delivered from lipid nanovesicles (LNs) decorated with surface transferrin (Tf) and co-encapsulated with HePc to reach the brain by circumventing the BBB in glioma bearing mice. The targeted nanovesicles (228.3 ± 10 nm, -41.7 ± 4 mV) exhibited mucoadhesiveness with 2% w/v mucin suggesting their potential to increase brain drug bioavailability after IN administration. The optimized TLNs had controlled, tunable and significantly different release kinetics in simulated cerebrospinal fluid and simulated nasal fluid demonstrating efficient release of the payload upon reaching the brain. Drug synergy (combination index, 0.7) showed a 6.4-fold enhanced cytotoxicity against resistant U87MG cells compared to free drugs. In vivo gamma scintigraphy of 99mTc labeled LNs showed 500- and 280-fold increased brain concentration post 18 h of treatment. The efficacy of the TLNs increased by 1.8-fold in terms of survival of tumor-bearing mice compared to free drugs. These findings suggested that targeted drug synergy has the potential to intranasally deliver a high therapeutic dose of the chemotherapy agent (TMZ) and could serve as a platform for future clinical application." @default.
• W4200339073 created "2021-12-31" @default.
• W4200339073 creator A5015744111 @default.
• W4200339073 creator A5035562262 @default.
• W4200339073 creator A5050864207 @default.
• W4200339073 creator A5063174317 @default.
• W4200339073 creator A5064538692 @default.
• W4200339073 creator A5081498212 @default.
• W4200339073 date "2022-01-01" @default.
• W4200339073 modified "2023-09-30" @default.
• W4200339073 title "Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models" @default.
• W4200339073 cites W1971964492 @default.
• W4200339073 cites W1977284436 @default.
• W4200339073 cites W1979900568 @default.
• W4200339073 cites W2000347606 @default.
• W4200339073 cites W2000772129 @default.
• W4200339073 cites W2007861368 @default.
• W4200339073 cites W2025724408 @default.
• W4200339073 cites W2034854030 @default.
• W4200339073 cites W2045511561 @default.
• W4200339073 cites W2050031215 @default.
• W4200339073 cites W2054957915 @default.
• W4200339073 cites W2058069455 @default.
• W4200339073 cites W2059729412 @default.
• W4200339073 cites W2062133591 @default.
• W4200339073 cites W2064924580 @default.
• W4200339073 cites W2068261374 @default.
• W4200339073 cites W2087168650 @default.
• W4200339073 cites W2090175192 @default.
• W4200339073 cites W2096287682 @default.
• W4200339073 cites W2110685305 @default.
• W4200339073 cites W2133391517 @default.
• W4200339073 cites W2135062838 @default.
• W4200339073 cites W2219650439 @default.
• W4200339073 cites W2256556867 @default.
• W4200339073 cites W2322916630 @default.
• W4200339073 cites W2330012482 @default.
• W4200339073 cites W2523136354 @default.
• W4200339073 cites W2584693724 @default.
• W4200339073 cites W2597570800 @default.
• W4200339073 cites W2626614537 @default.
• W4200339073 cites W2742175809 @default.
• W4200339073 cites W2803052218 @default.
• W4200339073 cites W2804592477 @default.
• W4200339073 cites W2804818197 @default.
• W4200339073 cites W2887733435 @default.
• W4200339073 cites W2896506009 @default.
• W4200339073 cites W2910531243 @default.
• W4200339073 cites W2913207981 @default.
• W4200339073 cites W2922040645 @default.
• W4200339073 cites W2972376636 @default.
• W4200339073 cites W2981157871 @default.
• W4200339073 cites W2981540329 @default.
• W4200339073 cites W2988826640 @default.
• W4200339073 cites W2995313248 @default.
• W4200339073 cites W2997516063 @default.
• W4200339073 cites W3003863259 @default.
• W4200339073 cites W3033027852 @default.
• W4200339073 cites W3120170115 @default.
• W4200339073 cites W3157136730 @default.
• W4200339073 doi "https://doi.org/10.1039/d1nr05460k" @default.
• W4200339073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34897360" @default.
• W4200339073 hasPublicationYear "2022" @default.
• W4200339073 type Work @default.
• W4200339073 citedByCount "8" @default.
• W4200339073 countsByYear W42003390732022 @default.
• W4200339073 countsByYear W42003390732023 @default.
• W4200339073 crossrefType "journal-article" @default.
• W4200339073 hasAuthorship W4200339073A5015744111 @default.
• W4200339073 hasAuthorship W4200339073A5035562262 @default.
• W4200339073 hasAuthorship W4200339073A5050864207 @default.
• W4200339073 hasAuthorship W4200339073A5063174317 @default.
• W4200339073 hasAuthorship W4200339073A5064538692 @default.
• W4200339073 hasAuthorship W4200339073A5081498212 @default.
• W4200339073 hasConcept C126322002 @default.
• W4200339073 hasConcept C126511603 @default.
• W4200339073 hasConcept C142724271 @default.
• W4200339073 hasConcept C150903083 @default.
• W4200339073 hasConcept C178790620 @default.
• W4200339073 hasConcept C181389837 @default.
• W4200339073 hasConcept C185592680 @default.
• W4200339073 hasConcept C196822366 @default.
• W4200339073 hasConcept C207001950 @default.
• W4200339073 hasConcept C22814914 @default.
• W4200339073 hasConcept C2777389519 @default.
• W4200339073 hasConcept C2777658100 @default.
• W4200339073 hasConcept C2778227246 @default.
• W4200339073 hasConcept C2778402981 @default.
• W4200339073 hasConcept C2779130545 @default.
• W4200339073 hasConcept C2779820397 @default.
• W4200339073 hasConcept C2780035454 @default.
• W4200339073 hasConcept C2780964509 @default.
• W4200339073 hasConcept C502942594 @default.
• W4200339073 hasConcept C529278444 @default.
• W4200339073 hasConcept C71924100 @default.
• W4200339073 hasConcept C85663871 @default.
• W4200339073 hasConcept C86803240 @default.
• W4200339073 hasConcept C98274493 @default.

• next